| Product Name | MF | CAS | Details |
|---|
| LSKL, Inhibitor of Thrombospondin TSP-1 acetate | Details |
| sodium lauroyl-α-hydroxyethyl sulfonate | Details |
| 1H-Pyrazole-5-carboxamide, 4-(5-chloro-2-furanyl)-1,3-bis(2,4-difluorophenyl)-4,5-dihydro-5-methyl-N-[(4-methyl-2-morpholinyl)methyl | C27H25ClF4N4O3 | 2171015-78-2 | Details |
| (2-{[2-(2-fluorophenoxy)ethyl]sulfanyl}-1H-benzimidazol-1-yl)acetic acid | C17H15FN2O3S | 303134-93-2 | Details |
| 2-benzylsulfanyl-6-methoxy-4-methylquinazoline, 10 mM in DMSO | C17H16N2OS | 500272-00-4 | Details |
| H-Asp(OtBu)-OtBu HCl | C12H24ClNO4 | 1791-13-5 | Details |
| Cis-5-Norbornene-exo-2,3-dicarboxylic Anhydride | C9H8O3 | 2746-19-2 | Details |
| N-terminally acetylated Leu-enkephalin | Details |
| 8-(4-iodophenyl)-1,3,5,7-tetramethyl BODIPY | C19H19BF2IN2 | 250734-47-5 | Details |
| CS-B1628 | C15H19BrN2O4S | 1434643-33-0 | Details |
| T807, 10 mM in DMSO | C16H10FN3 | 1415379-56-4 | Details |
| 2-((9R,10S,11R,15S)-12,14-dioxo-9,10-dih, 10 mM in DMSO | C24H23NO4 | 475100-30-2 | Details |
| Datelliptium chloride hydrochloride | C23H28ClN3O | 157000-76-5 | Details |
| 2-(2-bromophenyl)-5-chloro-4H-3,1-benzoxazin-4-one, 10 mM in DMSO | C14H7BrClNO2 | 1234707-32-4 | Details |
| Fmoc-Cys(Acm)-OH, 10 mM in DMSO | C21H22N2O5S | 86060-81-3 | Details |
| (R)-Naroparcil | C19H17NO4S2 | 252647-51-1 | Details |
| 2-CHLOROMETHYL-1,1-DIOXO-1,2-DIHYDRO-1LAMBDA*6*-BENZO[D]ISOTHIAZOL-3-ONE, 10 mM in DMSO | C8H6ClNO3S | 13947-21-2 | Details |
| ((3S,5R)-5-((1H-1,2,4-Triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methyl 4-methylbenzenesulfonate | C21H21F2N3O4S | 149809-43-8 | Details |
| W140 HBr, 10 mM in DMSO | C16H27N2O4P | 1246817-25-3 | Details |
| Thalidomide-O-amido-PEG3-C2-NH2 TFA | C25H31F3N4O11 | 1957236-21-3 | Details |
| cis-1-(3-Chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride | C9H16Cl2N4 | 51229-78-8 | Details |
| BDCRB | C12H11BrCl2N2O4 | Details |
| COH-SR4, 10 mM in DMSO | C13H8Cl4N2O | 73439-19-7 | Details |
| N-(1-benzyl-4-piperidyl)adamantane-1-carboxamide, 10 mM in DMSO | C23H32N2O | 314030-54-1 | Details |
| 4-(9H-fluoren-9-ylmethoxycarbonylamino)-piperidine-1,4-dicarboxylic acid mono-tert-butyl ester, 10 mM in DMSO | C26H30N2O6 | 183673-66-7 | Details |
| Z-Asp(OBzl)-OH, 10 mM in DMSO | C19H19NO6 | 3479-47-8 | Details |
| T863, 10 mM in DMSO | C22H26N4O3 | 701232-20-4 | Details |
| Ethyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate | C27H28N4O5 | 503614-91-3 | Details |
| SOD1-Derlin-1 inhibitor 56-59, 10 mM in DMSO | C22H18N4OS | 2170170-27-9 | Details |
| Anisole-piperazine-methanone-benzothiazole-p-methylpiperidine, 10 mM in DMSO | C25H30N4O2S | 906258-69-3 | Details |
| IHMT-PI3Kδ-372 S-isomer, 10 mM in DMSO | C26H23F2N7O2 | 2429889-61-0 | Details |
| Adrenocorticotropic Hormone (ACTH) (4-10) TFA | Details |
| Protease-Activated Receptor-4 diTFA | Details |
| 4-(4-Amino-3-fluorophenoxy)-N-methylpicolinamide | C13H12FN3O2 | 757251-39-1 | Details |
| 1-(4-AMinophenyl)-5,6-dihydro-3-(4-Morpholinyl)-2(1h)-pyridinone | C15H19N3O2 | 1267610-26-3 | Details |
| SOD1-Derlin-1 inhibitor-1 | C19H12Br2N4OS | 840461-03-2 | Details |
| Thyrotropin-Releasing Hormone (TRH), Free Acid, 10 mM in DMSO | C16H21N5O5 | 24769-58-2 | Details |
| 2,5-Morpholinedione, 4-methyl-6-(1-methylethyl)-3-(phenylmethyl)- | C15H19NO3 | 2180287-51-6 | Details |
| (1R,5S,6r)-N-(2-methyl-1-((3-methylpyridin-2-yl)oxy)propan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide L(+)-Tartaric acid | C16H23N3O2.C4H6O6 | 2919211-45-1 | Details |
| Protease-Activated Receptor-4 diTFA, 10 mM in DMSO | Details |
| 3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one | C20H25N3O3 | 545445-44-1 | Details |
| N-[3,5-bis(trifluoroMethyl)phenyl]-N''-[(9R)-6''-Methoxycinchonan-9-yl]- Thiourea, 10 mM in DMSO | C29H28F6N4OS | 852913-25-8 | Details |
| Thalidomide-O-amido-C4-NH2 TFA, 10 mM in DMSO | C21H23F3N4O8 | 1799711-25-3 | Details |
| CY5-SE triethylamine salt | C43H58N4O10S2 | 1497420-70-8 | Details |
| 4-(2-chloro-4-methoxy-5-methylphenyl)-N-[(1A)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-N-(2-propyn-1-yl)-2-thiazolam | C27H28ClFN2OS | 2649012-21-3 | Details |
| 3-(2,6-dichlorobenzyl)-1-hexadecyl-2-methyl-1H-imidazol-3-ium iodide | Details |
| 3-(2,6-dichlorobenzyl)-1-hexadecyl-2-methyl-1H-imidazol-3-ium iodide, 10 mM in DMSO | Details |
| N4-benzyl-N2-methylquinazoline-2,4-diamine hydrochloride, 10 mM in DMSO | C16H17ClN4 | 1135272-09-1 | Details |
| Benzyl-piperazine-CO-benzothiazole-4-methylpiperidine, 10 mM in DMSO | C25H30N4OS | 906258-48-8 | Details |
| ZY-19489, 10 mM in DMSO | C24H32FN9 | 1821293-40-6 | Details |
| Methyl retinoate | C21H30O2 | 339-16-2 | Details |
| MOG peptide (35-55) , mouse, rat acetate | Details |
| Bz-RS-ISer(3-Ph)-Ome, 10 mM in DMSO | C17H17NO4 | 32981-85-4 | Details |
| EOB-DTPA | C23H33N3O11 | 158599-72-5 | Details |
| Fmoc-His-OH | C21H19N3O4 | 116611-64-4 | Details |
| Benzo[b]thiophene-7-propanoic acid, α-methoxy-4-[2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy]-, (αR)-, 10 mM in DMSO | C24H23NO5S | 849150-59-0 | Details |
| (4S,5R)-3-tert-butoxycarbony-2-(4-anisy)-4-phenyl-5-oxazolidinecarboxylic acid, 10 mM in DMSO | C22H25NO6 | 196404-55-4 | Details |
| Thrombin Receptor Activator for Peptide | Details |
| 1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(7-(1-methyl-1H-pyrazol-4-yl)-2,3,4,9-tetrahydro-1H-carbazol-3-yl)urea, 10 mM in DMSO | C24H21ClF3N5O | 2379727-88-3 | Details |
| Phenol, 2-methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]-, 1,1''-(hydrogen phosphate) | C36H39O12P | 735261-22-0 | Details |
| 1H-Benzimidazole-6-carboxamide, N-[3-(aminocarbonyl)-4,5,6,7-tetrahydrobenzo[b]thien-2-yl]- | C17H16N4O2S | 941185-83-7 | Details |
| Fmoc-L-glutamic acid 5-tert-butyl ester | C24H27NO6 | 71989-18-9 | Details |
| (S)-3-AMino-2-Methylpropanoic acid-HCl, 10 mM in DMSO | C4H10ClNO2 | 925704-45-6 | Details |
| 6-Phenyldihydropyrimidine-2,4(1h,3h)-dione, 10 mM in DMSO | C10H10N2O2 | 6300-95-4 | Details |
| 2,4-Dioxaspiro(5.5)undec-8-ene, 3-(2-furanyl)-, 10 mM in DMSO | C13H16O3 | 80499-32-7 | Details |
| 6''-hydroxydihydrocinchonidine | C19H24N2O2 | 5962-19-6 | Details |
| LSKL, Inhibitor of Thrombospondin TSP-1 acetate, 10 mM in DMSO | Details |
| (2R,3S,11bS)-9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11bH-pyrido[2,1-a]isoquinolin-2-ol | C19H29NO3 | 924854-62-6 | Details |
| (1S,2R)-Alicapistat, 10 mM in DMSO | C25H27N3O4 | 2221010-57-5 | Details |
| A2B receptor antagonist 2 hydrochloride | C12H15N5.ClH | 724-70-9 | Details |
| 2,3-dihydro-1H-indene-5-sulfonamide, 10 mM in DMSO | C9H11NO2S | 35203-93-1 | Details |
| 4-Pyridinecarboxaldehyde, 2-(2-pyridinyl)hydrazone, [C(E)]- | C11H10N4 | 2241017-37-6 | Details |
| EM-651, 10 mM in DMSO | C29 H31 N O4 | 182167-58-4 | Details |
| 1-[(5-methylisoxazol-3-yl)methyl]piperazine, 10 mM in DMSO | C9H15N3O | 173850-51-6 | Details |
| N-[2-nitro-4-(trifluoromethyl)phenyl]piperazine, 10 mM in DMSO | C11H12F3N3O2 | 58315-38-1 | Details |
| (6Z)-7-Phenyl-7-(3-Pyridinyl)-6-Heptenoic Acid | C18H19NO2 | 89667-39-0 | Details |
| 1-(2-fluorophenyl)-3-[5-(2-methoxyphenyl)-1,3,4-thiadiazol-2-yl]urea | C16H13FN4O2S | 426242-86-6 | Details |
| MMRi62, 10 mM in DMSO | C21H15Cl2N3O | 352693-80-2 | Details |
| N′-(2-Chloroethyl)-N-(4-methylcyclohexyl)-N-nitrosourea | C10H18ClN3O2 | 75219-93-1 | Details |
| Compound STK672155, 10 mM in DMSO | C27H21ClN2O7S | 339284-01-4 | Details |
| (2S)-4-biphenyl-4-yl-N-hydroxy-2-methyl-2-(methylsulfonyl)butanamide, 10 mM in DMSO | C18H21NO4S | 1354546-42-1 | Details |
| Adrenocorticotropic Hormone (ACTH) (4-10) TFA, 10 mM in DMSO | Details |
| 2-(2-fluoro-6-methoxyphenyl)pyrimidine-4-carboxylic acid | C12H9FN2O3 | 1502645-66-0 | Details |
| Phos-tag Acrylamide AAL-107 | C33H38N8O3 | 871839-54-2 | Details |
| 1-benzyl-2-ethyl-4,5,6,7-tetrahydro-1H-indol-4-one, 10 mM in DMSO | C17H19NO | 218934-50-0 | Details |
| 2,3-BIS(N-BUTYLTHIO)-1,4-NAPHTHALENEDION | C18H22O2S2 | 671189-54-1 | Details |
| 1H-Indole, 3,3''-(2-thienylmethylene)bis[2-methyl- | C23H20N2S | 138801-72-6 | Details |
| DDG-39, 10 mM in DMSO | C9H12FN3O3 | 119555-47-4 | Details |
| 3-Phenyl-N-[1-(phenylmethyl)-4-piperidinyl]-tricyclo[3.3.1.13,7]decane-1-carboxamide, 10 mM in DMSO | C29H36N2O | 1252187-41-9 | Details |
| 6-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]- | C26H31N3O2 | 1314134-92-3 | Details |
| 1H-Pyrrolo[2,1-c][1,2,4]benzothiadiazine, 2,3,3a,4-tetrahydro-, 5,5-dioxide, (3aR)-, 10 mM in DMSO | C10H12N2O2S | 175340-21-3 | Details |
| (2S,3S)-3-Hydroxy-2-methyl-3-phenylpropanoic acid | C10H12O3 | 76549-02-5 | Details |
| T6167923, 10 mM in DMSO | C17H20BrN3O3S2 | 2437475-16-4 | Details |
| 4-benzyloxycarbonylamino-piperidine-1,4-dicarboxylic acid mono-tert-butyl ester, 10 mM in DMSO | C19H26N2O6 | 288154-16-5 | Details |
| Xanthine oxidoreductase-IN-5 | C17H17N5O2 | 1026652-90-3 | Details |
| 2-chloro-5-(16,18-dioxo-17-azapentacyclo[6.6.5.0~2,7~.0~9,14~.0~15,19~]nonadeca-2,4,6,9,11,13-hexaen-17-yl)benzoic acid, 10 mM in DM | C25H16ClNO4 | 327033-56-7 | Details |
| N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(N-ethylcyclopropanecarboxamido)-4-methyl-4′-morpholino-[1,1′-biphenyl]-3-c | C32H38N4O4 | 2238820-26-1 | Details |
| Rel-5-(4-Chloro-2-fluorophenyl)-2,3-dimethyl-7-[(2R,4S)-tetrahydro-2-(1-methyl-1H-pyrazol-4-yl)-2H-pyran-4-yl]pyrido[3,4-b]pyrazine | C24H23ClFN5O | 2738485-99-7 | Details |
| Nav1.8-IN-1, 10 mM in DMSO | C20H15ClF3N3O2 | 1026822-49-0 | Details |
| 3,7-dimethylocta-2,6-dienyl 5,9,13-trimethyltetradeca-4,8,12-enoate, 10 mM in DMSO | C27H44O2 | 16898-88-7 | Details |
| Product Total： Product Page： | ||||
| 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 | ||||